Patent Portfolios and Competition Law: Some Reflections After the Recent RPSA Cases
In the pharmaceutical sector, firms often build patent portfolios in order to better protect their innovations, but also to strategically exploit the cluster to prevent entry by generic competition. In fact, once patent protection on the main invention expires, originator firms adopt a two-tiered s...
Saved in:
Main Author: | Emanuela Arezzo |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade Católica Editora
2023-06-01
|
Series: | Market and Competition Law Review |
Subjects: | |
Online Access: | https://revistas.ucp.pt/index.php/mclawreview/article/view/12677 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MARKETING STRATEGIES DEVELOPMENT APPROACHES FOR MANAGING PATENT PORTFOLIOS
by: R. Tokarev
Published: (2017-07-01) -
Patent portfolios and Patent Assertion Entities: antitrust issues and future perspective under the Unified Patent Court
by: Pietro Cappabianca
Published: (2024-06-01) -
A bad dream come true: ICT patent prosecution against EU competition law
by: Niccolò Galli
Published: (2022-11-01) -
Patent search and analysis supporting technology innovation
by: Bin LIU, et al.
Published: (2016-03-01) -
Patent Analysis in the Grain Storage Sector
by: DU Shang-qiu, et al.
Published: (2025-01-01)